Pliant Therapeutics, Inc.

NASDAQ:PLRX

15.19 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -161.336-123.321-97.263-41.533-0.631-30.276-18.333
Depreciation & Amortization 1.8411.8231.5351.311.1130.6660.292
Deferred Income Tax -4.952000-12.19500
Stock Based Compensation 44.48322.59810.4373.8951.8290.2280.033
Change In Working Capital 1.2514.2176.917-1.209-5.0611.0540.893
Accounts Receivables 1.9830.0157.281-2.227-7.052-0.250
Inventory 0000.1133.19600
Accounts Payables 2.969-1.3510.8910.922-1.2550.760
Other Working Capital -3.7015.553-1.255-0.0170.050.2940.893
Other Non Cash Items 2.3520.0522.9310.26612.1951.050.191
Operating Cash Flow -116.361-94.631-75.443-37.271-2.75-28.328-16.924
Investing Activities:
Investments In Property Plant And Equipment -0.921-1.76-1.953-1.532-0.964-2.323-1.405
Acquisitions Net 126.091148.444-75.652209.3340.25400
Purchases Of Investments -583.069-325.716-219.887-322.605-51.96700
Sales Maturities Of Investments 456.978177.272295.539113.2713500
Other Investing Activites -126.091-148.44475.652-209.334-0.25400
Investing Cash Flow -127.012-150.20473.699-210.866-17.931-2.323-1.405
Financing Activities:
Debt Repayment 0-1000000
Common Stock Issued 275.252217.5612.984160.75148.1210.0320
Common Stock Repurchased 000000-0.012
Dividends Paid 0000000
Other Financing Activities -0.8479.293-0.45752.46145.53987.31720.018
Financing Cash Flow 274.405226.8542.527213.21245.53987.34920.006
Other Information:
Effect Of Forex Changes On Cash -1.483000000
Net Change In Cash 29.549-17.9810.783-34.92524.85856.6981.677
Cash At End Of Period 63.23433.68451.66550.88285.80760.9494.251